The Drugs Control Administration (DCA) in Telangana has introduced a bulk SMS alert system to notify pharmacies and drug wholesalers about medicines that fail quality standards. The initiative aims to ensure that substandard medicines are quickly identified and removed from sale before they reach patients.
Under this system, registered pharmacies and wholesale drug distributors across the state receive text message alerts whenever a medicine batch is declared “Not of Standard Quality” (NSQ) after laboratory testing. The alerts instruct medical shops to immediately stop selling the identified product and check their stock to ensure the affected batch is withdrawn.
Health regulators say the system strengthens communication between drug authorities and retail pharmacies, allowing faster action when medicine quality concerns arise.
Medicines classified as Not of Standard Quality (NSQ) are those that fail to meet the required standards during laboratory testing. Drug samples collected from the market are tested at government laboratories to verify whether they meet the specifications set under the Drugs and Cosmetics Act.
These tests evaluate several parameters such as the amount of active ingredient, dissolution rate, and disintegration properties. If a medicine fails these tests, it may not deliver the expected therapeutic effect. In some cases, improper dosage levels or poor dissolution can affect how the drug works in the body.
Once a drug batch is identified as NSQ, regulatory authorities issue instructions to stop its sale and distribution.
The primary objective of the SMS alert system is to improve the speed at which safety warnings reach pharmacies. Previously, information about substandard medicines was circulated through official notices or regulatory communication channels, which could take time to reach every pharmacy.
With the SMS system, the Drugs Control Administration can send alerts simultaneously to a large network of medical shops and wholesalers across the state. This enables pharmacies to act immediately by checking their inventory and discontinuing the sale of the flagged drug.
Regulators believe faster communication can help reduce the circulation of medicines that fail quality checks.
When the state drug testing laboratory identifies a medicine batch that does not meet quality standards, the Drugs Control Administration prepares an official alert. The system then sends a bulk SMS to registered pharmacies and wholesale drug dealers.
The message typically includes details such as the name of the drug, batch number, and manufacturer, along with instructions to stop the sale and distribution of the product.
Pharmacies receiving the alert are expected to verify whether the flagged batch is present in their stock and take steps to remove it from sale.
Soon after the launch of the SMS alert system, the Drugs Control Administration issued a warning regarding a batch of ZOFMOX-CV syrup, which had failed laboratory quality testing. Pharmacies were directed to stop selling the batch immediately and ensure it was withdrawn from the supply chain.
Such alerts help prevent medicines that do not meet regulatory standards from remaining available in the market.
Drug regulators routinely collect medicine samples from pharmacies and distributors to monitor quality. These samples are tested in laboratories to confirm compliance with approved specifications.
The SMS alert system adds a faster communication layer to this monitoring process. By informing pharmacies immediately after a drug fails testing, authorities can support quicker withdrawal of substandard medicines.
For patients, the initiative is intended to reduce the risk of receiving medicines that may not perform as expected due to quality issues.
The new system establishes a direct communication channel between regulators and pharmacies. By delivering alerts in real time, the Drugs Control Administration aims to improve coordination across the pharmaceutical supply chain and ensure that quality-related warnings reach the point of sale quickly.
(Rh/SS/MSM)
